KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesR&D In ProcessReceivables - NetReceivables - OtherShares Repurchased
Ratios

Eli Lilly (LLY) Long-Term Debt Issuances (2016 - 2025)

Eli Lilly (LLY) has disclosed Long-Term Debt Issuances for 12 consecutive years, with -$200000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Issuances fell 100.0% year-over-year to -$200000.0, compared with a TTM value of $13.2 billion through Dec 2025, up 15.33%, and an annual FY2025 reading of $13.2 billion, up 15.33% over the prior year.
  • Long-Term Debt Issuances was -$200000.0 for Q4 2025 at Eli Lilly, down from $6.7 billion in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $6.7 billion in Q3 2025 and bottomed at -$200000.0 in Q4 2025.
  • Average Long-Term Debt Issuances over 4 years is $3.4 billion, with a median of $4.0 billion recorded in 2023.
  • The sharpest move saw Long-Term Debt Issuances soared 124.53% in 2021, then tumbled 120.0% in 2024.
  • Year by year, Long-Term Debt Issuances stood at $2.4 billion in 2021, then crashed by 99.98% to $500000.0 in 2023, then tumbled by 120.0% to -$100000.0 in 2024, then plummeted by 100.0% to -$200000.0 in 2025.
  • Business Quant data shows Long-Term Debt Issuances for LLY at -$200000.0 in Q4 2025, $6.7 billion in Q3 2025, and $6.5 billion in Q1 2025.